EXOZYMES INC. — Capital/Financing Update 2026

Apr 10, 2026

Field: Rule-Page

Field: /Rule-Page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Field: Rule-Page

Field: /Rule-Page

FORM 8-K

Current Report Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):

April 10, 2026

EXOZYMES INC.

(Exact name of registrant as specified in its charter)

Nevada	001-42204	83-4550057
(State
or other jurisdiction of
incorporation)	(Commission File
Number)	(I.R.S.
Employer Identification
No.)

750 Royal Oaks Drive , Suite 106

Monrovia , CA 91016

(Address of principal executive offices and zip code)

Registrant’s telephone number, including area code: (626) 415-1488

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

| ☐ | Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| --- | --- |
| ☐ | Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |

Securities registered pursuant to Section 12(b) of the Exchange Act:

| Title
of each class | Trading
Symbol(s) | Name
of each exchange on which registered |
| --- | --- | --- |
| Common Stock | EXOZ | Nasdaq Capital Market |

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Field: Rule-Page

Field: /Rule-Page

Field: Page; Sequence: 1

Field: /Page

Item 8.01 — Other Events.

Attached is an Investor Presentation of eXoZymes Inc., a Nevada corporation, as of April 10, 2026, that is being provided to the potential underwriters and other offering participants for the proposed offering of securities by the Company.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

| Exhibits | Description
of Exhibit |
| --- | --- |
| 99.1 | Investor
Presentation of eXoZymes Inc. for April 10, 2026. |
| 104 | Cover Page Interactive
Data File (embedded within the Inline XBRL Document). |

Field: Page; Sequence: 2

Field: /Page

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

| Date:
April 10, 2026 | |
| --- | --- |
| By | /s/
Fouad Nawaz |
| | Fouad Nawaz, |
| | Vice President, Finance |

Field: Page; Sequence: 3; Options: Last

Field: /Page

Field: Set; Name: xdx; ID: xdx_08B_extensions eJxFjdEKwjAMRb9g/xD6LFsdOtjedKiIU2SI+FpclOLWjLRO/ST/0rohhkBI7j25QozEipa6RobTvCzggE1bK4dQ4gUZzRm9I19vMvCzxKu2jpVx/foDc/IMeiYJp8rfe2enLVYZyEkk0yhOQKbZJIHZVgRfPSdz0RUap1UNylSwZ2pZo1P8Gj4c1JMMNa8+6YhsNZkMxqEc5DfEchzDjjr1IL5ZKIpcBKO+ArFiurfetXg6NF8SFjU2Ps4O9L+DD8ydSl0=